Found 8 matching trials
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer NA This retrospective study aimed at assessment of different patterns (morphol...
Show More Location
Urology and Nephrology Center
Learn More & Join Trial
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC PHASE2 The goal of this clinical trial is to learn whether a combination of two ch...
Show More Location
University of Iowa
Learn More & Join Trial
Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ PHASE2 The purpose of this study is to evaluate the efficacy and tolerability of V...
Show More Location
Southeastern Research Group, Inc.
Learn More & Join Trial
Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure PHASE2 To study the safety and efficacy of CG0070, an oncolytic virus expression G...
Show More Location
Alaska Clinical Research Center
Learn More & Join Trial
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer PHASE1 The purpose of this study is to test the safety of avelumab and Bacille Cal...
Show More Location
Stephenson Cancer Center
Learn More & Join Trial
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder PHASE1 Upon successful screening and registration, enrollment to a cohort will beg...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study PHASE2 This open-label, randomised, multicentre, phase 2 study (OHAI-NMIBC-01) com...
Show More Location
The First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration PHASE2 This is a single-center, prospective, open-label, non-randomized clinical s...
Show More Location
ChangHai Hospital
Learn More & Join Trial